Evidence map›Paper›PMID 18308397›Full record

ArticleMolecular immunology2008

Inhibition of IL-1beta transcription by peptides derived from the hCMV IE2 transactivator.

James A Listman, JoAnne E Race, Nancy Walker-Kopp, Sebnem Unlu, Philip E Auron

Open access · greenAbstract read
In one paragraph

Article in Molecular immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

James A ListmanSUNY Upstate Medical University, Syracuse, NY 13210, USA. listmanj@upstate.edu
JoAnne E Race
Nancy Walker-Kopp
Sebnem Unlu
Philip E Auron
SUNY Upstate Medical University · US

Funding

ACCESSORY CELL ACTIVATION OF THE IMMUNE RESPONSER01CA068544 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI AURON, PHILIP E · 1995 to 2004
$1.3M
IL-1 RECEPTOR MEDIATED SIGNAL TRANSDUCTIONR01AI044122 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI AURON, PHILIP E · 1999 to 2003
$1.2M
REGULATION OF THE IL1 BETA GENE BY CMV IE PROTEINSK08DK002788 · NIDDK · UPSTATE MEDICAL UNIVERSITY · PI LISTMAN, JAMES A · 1999 to 2003
$519k
NCI NIH HHS CA068544NCI NIH HHS R01 CA068544NIAID NIH HHS R01 AI044122NIDDK NIH HHS K08 DK002788NIDDK NIH HHS K08DK002788
6 · The paper itself

Abstract

The immediate early (IE) proteins of human cytomegalovirus (hCMV) have diverse roles in directing viral and host cell transcription. Among these is the ability of IE2 to induce transcription of the IL1B gene that codes for IL-1beta in monocytes. This function is partially explained by interaction between IE2 and the host cell transcription factor Spi-1/PU.1 (Spi-1). We now show that maximal IE2 function also depends on productive interactions localizing to two C/EBP sites on the IL1B promoter suggesting either bi- or tri-molecular interactions between IE2, Spi-1 and C/EBPbeta at two different locations on the promoter. The IE2 interaction region on Spi-1 was previously mapped to the DNA-binding ETS domain and overlaps the region of Spi-1 that interacts with the transcription factor C/EBPbeta, a factor known to be critical for the induction of IL1B in response to Toll/IL-1 receptor (TIR) family signal transduction. The Spi-1 interacting region of IE2 maps to amino acids 315-328, a sequence that also interacts with the bZIP domain of C/EBPbeta. An expression vector coding for amino acids 291-364 of IE2 can suppress LPS induction of a co-transfected IL1B enhancer-promoter fragment in a monocyte cell line. This inhibition is likely the result of competition between Spi-1 and C/EBPbeta, thus blunting gene induction.

Indexed as

Transcription, GeneticCCAAT-Enhancer-Binding Protein-betaCell LineCytomegalovirusHeLa CellsHumansImmediate-Early ProteinsInterleukin-1betaPeptidesPromoter Regions, GeneticProtein Structure, TertiaryProto-Oncogene ProteinsProto-Oncogene Protein Spi-1Trans-ActivatorsTransfectionCCAAT-Enhancer-Binding Protein-betaIE2 protein, CytomegalovirusImmediate-Early ProteinsInterleukin-1betaPeptidesProto-Oncogene ProteinsProto-Oncogene Protein Spi-1Trans-Activators

Identifiers

PMID18308397
PMCPMC2363159
OpenAlexW2166481748

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.